IP Library Granted Patent US 9,637,776
Granted Patent B2
US 9,637,776 · App. 12/120,586 · Granted May 2, 2017

Methods of identifying an organism

Inventor: Adam M. Briska (Madison, WI)
Assignee: OpGen, Inc.
C12Q1/683G06F19/22G06F19/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,637,776
App. No.
12/120,586
Granted
May 2, 2017
Kind
B2
Abstract

This disclosure features methods of identifying an organism. The methods include: (a) obtaining a nucleic acid sample from an organism; (b) imaging said nucleic acid; (c) obtaining a restriction map of said nucleic acid; and (d) correlating the restriction map of said nucleic acid with a restriction map database, thereby identifying the organism.

Claims (22)

1. A method of identifying an organism, the method comprising:

(a) preparing an optical map of a nucleic acid that has been obtained from an organism from a sample, wherein preparing comprises digesting the nucleic acid with one or more enzymes;

(b) providing a restriction map database that comprises ordered restriction maps from known organisms that have been generated using the same one or more enzymes from step (a), and for which unique motifs have been identified;

(c) aligning the optical map against the motifs;

(d) determining one or more motif matches between the nucleic acid from the sample and the unique motifs from the database; and

(e) identifying the organism by determining a best motif match.

2. The method of claim 1 , wherein the organism is a microorganism.

3. The method of claim 1 , wherein the organism is a bacterium.

4. The method of claim 1 , wherein the organism is a virus.

5. The method of claim 1 , wherein the organism is a fungus.

6. The method of claim 1 , wherein said nucleic acid comprises all genomic DNA of said organism.

7. The method of claim 1 , wherein said nucleic acid comprises a transcriptome of said organism.

8. The method of claim 1 , wherein said nucleic acid is deoxyribonucleic acid.

9. The method of claim 1 , wherein said nucleic acid is ribonucleic acid.

10. The method of claim 1 , wherein the sample is a human tissue or body fluid.

11. The method of claim 1 , wherein the enzymes are selected from the group consisting of: BglII, NcoI, XbaI, and BamHI.

12. The method of claim 1 , wherein the preparing step further comprises imaging the digested nucleic acid.

13. The method of claim 1 , wherein the database comprises a restriction map similarity cluster.

14. The method of claim 1 , wherein the database comprises a restriction map from at least one member of a clade of organisms.

15. The method of claim 1 , wherein the database comprises a restriction map from at least one subspecies of organisms.

16. The method of claim 1 , wherein the database comprises a restriction map from a genus, a species, a strain, a sub-strain, or an isolate of organisms.

17. The method of claim 1 , wherein the unique motifs are motifs common to a genus, a species, a strain, a sub-strain, or an isolate of organisms.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 3, 2021
From: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
To: OPGEN, INC.; ADVANDX, INC.
Reel/Frame 055209/0242 →
SECURITY INTEREST Recorded Aug 17, 2015
From: OPGEN, INC.; ADVANDX, INC.
To: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
Reel/Frame 036377/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2008
From: BRISKA, ADAM
To: OPGEN, INC.
Reel/Frame 021820/0788 →
Continuity (2)
Provisional Application 61029816 · Feb 19, 2008
Related Publication 20120164133A1 · Jun 28, 2012